Biotech

All Articles

Novartis ignites new stage of Voyager contract along with $15M capsid deal

.Novartis is opening a brand-new outpost in its collaboration with Voyager Rehabs, spending $15 mill...

Lilly articles a lot more beneficial records on its own every week blood insulin possibility

.On the heels of an FDA being rejected for its main competing Novo Nordisk, Eli Lilly is pulling ahe...

IN 8bio stops stage 2 trial, gives up fifty percent of staff

.Simply a couple of months after dosing the very first client in a stage 2 test for freshly diagnose...

Lilly, Haya ink $1B biobuck excessive weight contract to explore dark genome

.Eli Lilly's look for being overweight targets has led it to the dark genome. The Big Pharma has cra...

ArsenalBio raises $325M, pivots away from former lead asset

.Toolbox Biosciences is proceeding up. The cell treatment business has added $325 million in ammunit...

Lilly- backed weight management biotech data IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has submitted to...

Aelis' marijuana usage medication fails period 2b, driving Indivior to reassess $100M choice

.Aelis Farma's hopes of getting a simple, beneficial decision on a $100 million possibility payment ...

ProKidney stops stage 3 test certainly not needed to have for cell therapy permission

.ProKidney has ceased among a pair of period 3 trials for its tissue therapy for kidney ailment afte...

Vaxcyte surges on 'spectacular' 31-valent PCV gain against Pfizer

.Vaxcyte introduced what experts referred to as "remarkable" stage 1/2 data for its own 31-valent pn...

Recursion's human brain disease test reveals little evidence of effectiveness

.Recursion has discovered via a very early examination of its tech-enabled technique to medicine exp...